2 recruiting, 2 terminated, 1 enrolling by invitation. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 2, Terminated 2, Enrolling by invitation 1 |
Follow Capsicure, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs Microlyte®, IP 1: Membrane Wrap - Hydro - Wound, Foot, Diabetic Foot Ulcer (DFU) | Not applicable | Recruiting | Capsicure, LLC | 147 | 2026-06-22 | 2026-07-14 |
| BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation cureVision cV - DFU, VLU | Not applicable | Enrolling by invitation | Capsicure, LLC | 100 | 2026-06-10 | 2026-06-11 |
| CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap, IP2: BioLab Tri-Membrane Wrap - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer | Not applicable | Recruiting | Capsicure, LLC | 165 | 2025-10-01 | 2025-10-22 |
| Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone Amnio-Maxx - Diabetic Foot Ulcer | Not applicable | Terminated | Capsicure, LLC | 74 | 2024-10-25 | 2026-05-28 |
| Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone Derm-Maxx - Diabetic Foot Ulcer | Not applicable | Terminated | Capsicure, LLC | 120 | 2024-10-25 | 2026-05-28 |
Diabetic Foot (4) · Foot Injuries (2) · Pressure Ulcer (1) · Surgical Wound (1) · Varicose Ulcer (1) · Wounds and Injuries (1)
United States (5)
Windy Cole, DPM (4) · Marissa Docter, RN, BSN, MD (2)